...
机译:佐剂化疗不会改善FOGPA阶段IC卵巢颗粒细胞肿瘤的无病生存:MITO-9研究
Ist Sci San Raffaele Dept Gynecol Via Olgettina 60 I-20132 Milan Italy;
Ist Sci San Raffaele Dept Gynecol Via Olgettina 60 I-20132 Milan Italy;
Univ Bari Dept Obstet &
Gynecol Bari Italy;
Univ Bari Dept Obstet &
Gynecol Bari Italy;
S Orsola Malpighi Univ Hosp Dept Gynecol Oncol Bologna Italy;
Natl Canc Inst Regina Elena Div Med Oncol Rome Italy;
Ist Sci San Raffaele Dept Gynecol Via Olgettina 60 I-20132 Milan Italy;
Natl Canc Inst Dept Gynecol Oncol CRO Aviano Italy;
IRCCS Fdn Policlin Mangiagalli Regina Elena Hosp Dept Obstet &
Gynecol Milan Italy;
Natl Canc Inst Fdn Giovanni Pascale Urogynecol Oncol Naples Italy;
Riuniti Bergamo Hosp Dept Gynecol Bergamo Italy;
Univ Pisa Dept Clin &
Expt Med Div Obstet &
Gynecol Pisa Italy;
Sapienza Univ Rome Dept Gynecol Obstet &
Urol Rome Italy;
Univ Molise Policlin Univ Agostino Gemelli Campobasso Gynecol Oncol Unit Dept Hlth Sci &
Med;
Granulosa cell tumors of the ovary; Adjuvant chemotherapy; Stage IC; Prognostic factors; Relapse; MITO;
机译:MITO-9研究表明,辅助化疗不能改善FIGO期IC卵巢颗粒细胞瘤的无病生存率
机译:阶段和辅助化疗在阶段的恶性卵巢胚芽细胞肿瘤(驯化)中的作用:MITO-9研究
机译:辅助化疗是否有益于卵巢的Figo阶段IC成年颗粒细胞瘤的患者?
机译:计算机提取与空间相关的功能肿瘤浸润淋巴细胞的安排预测上皮性卵巢癌接受佐剂化疗的整体存活
机译:基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
机译:辅助化疗对FIGO期IC分期成年卵巢颗粒细胞瘤的患者有益吗?
机译:手术或手术联合辅助化疗治疗小儿Ⅱ期睾丸恶性生殖细胞肿瘤的生存分析